-
1
A rare late progression form of Sly syndrome mucopolysaccharidosis
Published 2019-09-01Subjects: Get full text
Article -
2
Diagnosis and Emerging Treatment Strategies for Mucopolysaccharidosis VII (Sly Syndrome)
Published 2022-12-01Subjects: Get full text
Article -
3
Description of the molecular and clinical characteristics of the mucopolysaccharidosis type VII Iberian cohort
Published 2021-10-01Subjects: Get full text
Article -
4
-
5
#322 : A Rare Case Report of Successfull Live Twin Birth in a Couple Who are Carriers of Mucopolysaccharidoses VII-Sly Syndrome
Published 2023-12-01“…So far 9 pregnancies have been recorded in patients with sly syndrome of which the majority showed some deformity. …”
Get full text
Article -
6
Dose-dependent effects of enzyme replacement therapy on skeletal disease progression in mucopolysaccharidosis VII dogs
Published 2023-03-01Subjects: Get full text
Article -
7
Long-Term Follow-up Posthematopoietic Stem Cell Transplantation in a Japanese Patient with Type-VII Mucopolysaccharidosis
Published 2020-02-01Subjects: Get full text
Article -
8
Prenatal mucopolysaccharidosis VII: A novel pathogenic variant identified in GUSB gene
Published 2021-02-01Subjects: Get full text
Article -
9
-
10
Mechanism of Secondary Ganglioside and Lipid Accumulation in Lysosomal Disease
Published 2020-04-01“…Chondroitin sulfate effectively inhibits GM2 catabolism in mucopolysaccharidoses like Hurler, Hunter, Sanfilippo, and Sly syndrome and causes a secondary neuronal ganglioside GM2 accumulation, triggering neurodegeneration. …”
Get full text
Article -
11
Theoretical investigation and design of some indole derivatives as potent β-glucuronidase inhibitors
Published 2020-07-01“…Lack of β-glucuronidase enzyme leads to Sly syndrome in humans, and overexpression of this enzyme leads to many diseases. …”
Get full text
Article -
12
Mucopolysaccharidosis VII in Brazil: natural history and clinical findings
Published 2021-05-01“…Abstract Background Mucopolysaccharidosis type VII (MPS VII), also known as Sly syndrome, caused by deficiency of the lysosomal enzyme β-glucuronidase, is an ultra-rare disorder with scarce epidemiological data and few publications about natural history and clinical spectrum. …”
Get full text
Article